Table 2.
Selection Criteria
| Condition | Contraindication (CI) or Physician Discretion (PD) | Timing to Filler Rx | Suggestions |
|---|---|---|---|
| Chemotherapy | CI on Rx | > 6m after completion | Immunosuppression documented 6 months after adjuvant Rx; Consider psychological needs. Informed consent. |
| Radiotherapy | PD | > 6 m | Vigilant follow-up |
| Immunotherapy | PD; Postpone | Insistent pt with subsequent LOAEs: No systemic steroids! Rx: AB, ± I/L steroids Caution: tumor - mimicking filler types (scans) |
|
| Previous LOAE | 1 m after full clearance | Exclude previous trigger factors | |
| Acne | Pre-Rx | Clearance | Topical: Pre-Rx entire acne area Increased resistant P acnes at edge of topically Rx area; No safe distance |
| Rosacea | Barrier Fx decreased | 1–3 m | |
| Perioral dermatitis | 6 weeks | ||
| Dermatitis | Barrier Fx decreased | 1 m after clearance | Caution: allergies, staph carriers, eczema herpeticum |
| Autoimmune collagenoses | Active: CI | Check parameters; Rheumatology consult | |
| Rheumatoid Arthritis | Active: CI | Stable: skin test before injection | |
| Systemic lupus erythematosus | Active: CI | Stable: skin test before injection | |
| Mixed Connective Tissue Disease | CI | ||
| Thyroid | Hashimoto: CI | Burnt-out Hashimoto’s: may treat | |
| Diabetes | PD | Decreased tissue healing | |
| Active HSV | CI | Prophylaxis: start 1-day pre-Rx Full 5 days of Rx |
Infective until last crust disappeared HSV prophylaxis pre-procedural Treatment history? Resistance |
| Porphyria | PD drug intolerances | Caution: treatment of potential A/E’s - drug C/I’s | |
| Pregnancy | CI | No safety data; Medicolegal implications | |
| Lactation | PD | ||
| Body dysmorphic disorder | PD | Complications | |
| Transgender (Transitioning) | Psychiatric counselling, informed consent and photo-documentation Hormone-induced acne, especially female to male transitioning |
||
| HIV | PD | Full-blown AIDS: CI | |
| Chronic urticaria | CI | ||
| Severe allergies (multiple) | PD | 2–4 weeks between | Enquire re vaccination protocols |
| Vaccinations COVID-19 SARS2 | Filler and vaccination (Unknown: suggested 2-4 weeks) |
Prophylactic lisinopril may be attempted
|
Abbreviations: CI, contraindicated; PD, physician discretion; AB, antibiotics; I/L, intralesional; m, month; A/E, adverse events; LOAE, late onset adverse events; AIDS, acquired immunodeficiency syndrome.